SCHEMBL8042352

SCHEMBL8042352

CCCCOC(=O)N1CCC(C(=O)ON2C(=O)CCC2=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
POLB P06746 1/20 0.47
GAA P10253 2/20 0.43
CHRM1 P11229 2/20 0.41
CHRM2 P08172 1/20 0.41
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 5/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HRH2 P25021 1/20 0.37
HRH1 P35367 1/20 0.37
HSP90AA1 P07900 1/20 0.37
TSHR P16473 1/20 0.37
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664936 0.82 LMNA (0.58) LMNASMN1; SMN2POLBGAACHRM1
SCHEMBL337723 0.80 GNAI3 (0.52) POLBKMT2ATDP1ALDH1A1NPC1
SCHEMBL12615399 0.80 MAPT (0.59) LMNASMN1; SMN2POLBGAACHRM1
SCHEMBL16102147 0.80 GAA (0.56) LMNASMN1; SMN2POLBGAACHRM1
SCHEMBL27997797 0.78 GAA (0.59) LMNASMN1; SMN2POLBGAACHRM1
SCHEMBL16049958 0.78 L3MBTL1 (0.41) LMNASMN1; SMN2POLBRAB9A
SCHEMBL7096747 0.77 SMN1; SMN2 (0.58) LMNASMN1; SMN2POLBGAACHRM1
SCHEMBL355693 0.77 SMN1; SMN2 (0.58) LMNASMN1; SMN2POLBGAACHRM1
SCHEMBL5494939 0.76 HPGD (0.52) KMT2AMAPTNPC1RAB9A
SCHEMBL5823241 0.76 GAA (0.73) LMNASMN1; SMN2POLBGAACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093718-A AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS ZENECA LIMITED (GB) 2000-07-25 US disclosed